Novo Nordisk and Combine in Research Collaboration
Novo Nordisk and the Swedish university consortium Combine have announced a research collaboration in the field of autoimmune diseases.
Pharma
Dr Reddy
Pharma major Dr Reddy
Gujarat’s Zydus Cadila to make India’s First H1N1 shot
The Ahmedabad-based pharmaceutical company, Zydus Cadila, could be the first Indian company to develop a vaccine for swine flu.
India
Diabetes Research Centre, Central Leather Research Institute (CLRI) and Medical Council of India organized a Multinational Study Group Meeting on
Biocon and HCG Group of Hospitals Ltd. Join Hands to Fight Against Cervical Cancer
Biocon and HCG group of hospitals have announced their partnership to conduct a study to uate the potential benefits of BIOMAb EGFR
DNA Electronics Wins R&D Prize At Elektra09 European Electronics Industry Awards
DNA Electronics Ltd, a developer of disposable, real-time gene testing at the point-of-care, has been named as the winner of the prestigious R&D prize at the Elektra09 European Electronics Industry Awards.
WHO to Supply Swine Flu Vaccines to Sri Lanka
The Sri Lankan Healthcare and Nutrition Ministry will receive 380,000 Novel Influenza (A) H1N1 vaccines from the World Health Organization (WHO) to cure patients suffering from swine flu in the country.
Wockhardt jumps on US FDA nod for generic drug
Wockhardt and Sun Pharmaceutical have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug.
Bharat Biotech
Bharat Biotech International, a leading manufacturer of vaccines and biotherapeutics announced its Anti-Staphylococcal Molecule
Pharma stocks in the pink of health
Shares of fourteen drug makers rose by 0.99% to 6.16% on reports global pharma firms are scouting for acquiring Indian drug makers, as generic penetration in the developed market is expected to increase in the coming years.
Pharma industry steps up recruitment 5 times
At a time when global multinational drug makers are slashing their workforces to reduce costs, their Indian counterparts are on a hiring spree.
Patent expiry to open huge opportunity
Patent expiry will be a major avenue of growth for the Indian pharmaceutical industry as products worth $235 billion are going off patent within horizon of five years (from 2009 to 2014).
Six new pharma research centers
Finally,the government has fulfilled the demand of pharmaceutical industry to meet its long-standing demand of trained manpower by giving in principle approval for setting up of six National Institutes of Pharmaceutical Education and Research (NIPER)
